ReviewPublished 5 October 2026Ethical challenges in the clinical translation of anti-amyloid monoclonal antibodies for Alzheimer’s disease: a scoping reviewAlexandra Wicker · Amanda Courtright-Lim · Jon TilburtFrontiers in Psychiatrydoi 10.3389/fpsyt.2026.1953954
Original ResearchPublished 1 October 2026Network-level restoration of impaired memory function in early Alzheimer’s disease via GluN2B modulation: insights from a hippocampal CA1–CA3 modelFabio Librizzi · Saana Seppälä · Marja-Leena Linne · Michele Migliore · Ausra SaudargieneFrontiers in Computational Neurosciencedoi 10.3389/fncom.2026.1953352
Original ResearchPublished 25 September 2026Virtual screening of phytochemicals against multiple protein targets of Alzheimer’s diseaseSamuel Mesfin · Naamah Bloch · Abraham O. SamsonFrontiers in Drug Discoverydoi 10.3389/fddsv.2026.1922953
ReviewPublished 29 July 2026Bioactive constituents of Hericium erinaceus: extraction strategies, health benefits and food applicationsVibhuti Gurung · Narashans Alok Sagar · Nitu RaniFrontiers in Natural Productsdoi 10.3389/fntpr.2026.1872464
ReviewPublished 11 June 2026Mechanistic insights into the synaptic damage-repair and regeneration processes in neurodegenerative Alzheimer’s disease: phytochemicals as neuroprotective agentsBharti Yadav · Prabhakar Gangwar · Kirti Kumari · Anuradha Yadav · Rashmi Rao · Keshav Kumar · Harkomal Verma · Monisha Dhiman · Anil Kumar ManthaFrontiers in Synaptic Neurosciencedoi 10.3389/fnsyn.2026.1835778
Original ResearchPublished 18 February 2026A Physics Informed Neural Network (PINN) framework for fractional order modeling of Alzheimer's diseaseAdnan Mehmood · Muhammad Farman · Farkhanda Afzal · Kottakkaran Sooppy Nisar · Mohammed Altaf Ahmed · Mohamed HafezFrontiers in Neuroinformaticsdoi 10.3389/fninf.2026.1748481
